Reuters logo
3 个月前
BRIEF-Apellis receives EMA orphan drug designation for APL-2
2017年5月9日 / 中午12点09分 / 3 个月前

BRIEF-Apellis receives EMA orphan drug designation for APL-2

May 9 (Reuters) - Apellis Pharmaceuticals Inc:

* Apellis receives EMA orphan drug designation for apl-2 in PNH Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below